Skip to main content
ABATED

Items

Funding to evaluate AI technology for timely and equitable dementia diagnosis

ABATED Study Funding Announcement

Date added: Monday, May 9, 2022


AINOSTICS granted FDA Breakthrough Device Designation

AINOSTICS has been awarded Breakthrough Device Designation by the US Food and Drug Administration (FDA) to the product, BR[AI]N.

Date added: Thursday, September 8, 2022


First ABATED focus group

Date added: Wednesday, November 2, 2022


Festival of Communities

Date added: Monday, June 12, 2023


Alzheimer's Association International Conference 2023

Date added: Thursday, July 20, 2023


Back to top